A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain


  • Stefania Giotti Cioato UFRGS
  • Liciane Fernandes Medeiros Unilasalle
  • Bettega Costa Lopes UFRGS
  • Helouise Richardt Medeiros UFRGS
  • Wolnei Caumo UFRGS
  • Rafael Roesler UFRGS
  • Iraci LS Torres UFRGS


adenosine A3 receptor, cytokine, DMSO, IB-MECA, neuropathic pain, neurotrophin, rats.


Introduction: Considering the lack of specific treatments to neuropathic pain, this study aimed to evaluate the effect of a single dose adenosine A3 receptor IB-MECA in the inflammatory and neurotrophic parameters of rats submitted to a neuropathic pain model. Methods: 64 adults male Wistar rats were used.  Neuropathic pain was induced by the chronic constriction injury (CCI) of sciatic nerve and the treatment consisted in one dose of 0.5 μmol/kg of a selective agonist of adenosine A3 receptor IB-MECA dissolved in 3% DMSO; vehicle groups received DMSO 3% in saline; morphine groups received 5mg/kg Cerebral cortex and hippocampus IL-1β, BDNF and NGF levels were determined by ELISA assay. Results: The key finding was that a single dose of IB-MECA was able to modulate the IL-1β hippocampus levels CCI and the DMSO increased IL-1β and NGF hippocampus levels in sham animals; however, when the DMSO as an IB-MECA vehicle, this effect was not observed, indicating that IB-MECA was able to prevent the effect of DMSO. Conclusions: Considering that the IL-1β role in neuropathic pain is quite explored, as well as the hippocampus contributions, our result corroborates the relationship of A3 receptor and the chronic pain maintenance process.


@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0in; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes;}div.WordSection1 {page:WordSection1;}


Não há dados estatísticos.




Como Citar

Cioato SG, Medeiros LF, Lopes BC, Medeiros HR, Caumo W, Roesler R, Torres IL. A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain. Clin Biomed Res [Internet]. 29º de julho de 2022 [citado 28º de setembro de 2022];42(2). Disponível em: https://seer.ufrgs.br/index.php/hcpa/article/view/116706



Artigos Originais

Artigos mais lidos pelo mesmo(s) autor(es)

1 2 > >>